Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where S. M. Griffin is active.

Publication


Featured researches published by S. M. Griffin.


British Journal of Surgery | 2000

Pattern of recurrence following radical oesophagectomy with two-field lymphadenectomy

Samuel M. Dresner; S. M. Griffin

Despite increasingly radical surgery for oesophageal cancer many patients continue to represent with recurrent disease. This study aimed to evaluate the pattern of failure following attempted curative oesophagectomy with mediastinal and upper abdominal lymphadenectomy.


British Journal of Surgery | 2014

Consensus guidelines for enhanced recovery after gastrectomy. Enhanced Recovery After Surgery (ERAS®) Society recommendations

Kim Erlend Mortensen; Magnus Nilsson; K. Slim; Markus Schäfer; C. Mariette; Marco Braga; Francesco Carli; Nicolas Demartines; S. M. Griffin; Kristoffer Lassen

Application of evidence‐based perioperative care protocols reduces complication rates, accelerates recovery and shortens hospital stay. Presently, there are no comprehensive guidelines for perioperative care for gastrectomy.


British Journal of Surgery | 2003

Human model of duodenogastro-oesophageal reflux in the development of Barrett's metaplasia†

Samuel M. Dresner; S. M. Griffin; J. Wayman; Mark K. Bennett; N. Hayes; S. A. Raimes

Patients with an intrathoracic oesophagogastrostomy after subtotal oesophagectomy experience profound duodenogastro‐oesophageal reflux (DGOR). This study investigated the degree of mucosal injury and histopathological changes in oesophageal squamous epithelium after subtotal oesophagectomy with gastric interposition in relation to the extent of postoperative DGOR.


British Journal of Cancer | 1999

Peritoneal cytology in the surgical evaluation of gastric carcinoma

N. Hayes; J. Wayman; V Wadehra; D Scott; S. A. Raimes; S. M. Griffin

SummaryMany patients undergoing surgery for gastric carcinoma will develop peritoneal metastases. A method to identify those patients at risk of peritoneal recurrence would help in the selection of patients for adjuvant therapy. Peritoneal cytology has received little attention in the West, but may prove a useful additional means of evaluating patients with gastric cancer. The aims of this study were to evaluate sampling techniques for peritoneal cytology in patients with gastric cancer, to assess the prognostic significance of free peritoneal malignant cells and to discover the effect of the operative procedure on dissemination of malignant cells. The study is based on 85 consecutive patients undergoing surgical treatment of gastric cancer and followed up for 2 years or until death. Peritoneal cytology samples were collected at laparoscopy, and at operation prior to resection by intraperitoneal lavage and serosal brushings. After resection, samples were taken by peritoneal lavage, imprint cytology of the resected specimen and post-operatively by peritoneal irrigation via a percutaneous catheter. Malignant cells were diagnosed by two independent microscopists. Preoperative peritoneal lavage yielded malignant cells in 16 out of 85 cases (19%). The yield of free malignant cells was increased by using serosal brushings (by four cases) and imprint cytology (by two cases); all of the cases had evidence of serosal penetration. One serosa-negative case exhibited positive cytology in the post-resection peritoneal specimen in which the preresection cytology specimen was negative. Survival was worse in the cytology-positive group (χ2 = 25.1; P < 0.0001). Among serosa-positive patients, survival was significantly reduced if cytology was positive, if cases yielded by brushings and imprint cytology were included (log-rank test = 8.44; 1 df, P = 0.004). In conclusion, free peritoneal malignant cells can be identified in patients with gastric cancer who have a poor prognosis; the yield can be increased with brushings and imprint cytology in addition to conventional peritoneal lavage. Evaluation of peritoneal cytology by these methods may have a role in the selection of patients with the poorest prognosis who may benefit most from adjuvant therapy.


British Journal of Surgery | 2005

Sentinel node biopsy to evaluate the metastatic dissemination of oesophageal adenocarcinoma

P. J. Lamb; S. M. Griffin; Alastair D. Burt; J. J. Lloyd; Dayalan Karat; N Hayes

The aim of this study was to determine the feasibility and accuracy of sentinel lymph node (SLN) biopsy for oesophageal adenocarcinoma.


British Journal of Cancer | 2002

The pattern of recurrence of adenocarcinoma of the oesophago-gastric junction

J. Wayman; Mark K. Bennett; S. A. Raimes; S. M. Griffin

Knowledge of the pattern of recurrence of surgically treated cases of adenocarcinoma of the oesophago-gastric junction is important both for better understanding of their biological nature and for future strategic planning of therapy. The aim of this study is to demonstrate and compare the pattern of dissemination and recurrence in patients with Type I and Type II adenocarcinoma of oesophago-gastric junction. A prospective audit of the clinico-pathological features of patients who had undergone surgery with curative intent for adenocarcinoma of oesophago-gastric junction between 1991 and 1996 was undertaken. Patients were followed up by regular clinical examination. Clinical evaluation was supported by ultrasound, computerised tomography, radio-isotope bone scan, endoscopy and laparotomy each with biopsy and histology where appropriate. One hundred and sixty-nine patients with oesophago-gastric junction tumours (94 Type I and 75 Type II) have been followed up for a median of 75.3 (57–133) months. One hundred and three patients developed proven recurrent disease. The median time to recurrence was 23.3 (14.2–32.4) months for Type I and 20.5 (11.6–29.4) for Type II cancers. The most frequent type of recurrence was haematogenous (56% of Type I recurrences and 54% of Type II) of which 56% were detected within 1 year of surgery. The most frequent sites were to liver (27%), bone (18%) brain (11%) and lung (11%). Local recurrence occurred in 33% of Type I cancer and 29% of Type II recurrences. Nodal recurrence occurred in 18 and 25% of Type I and Type II cancer recurrences, most frequently to coeliac or porta hepatis nodes (64%). Only 7% of Type I and 15% of Type II cancer recurrences were by peritoneal dissemination. Type I and Type II adenocarcinoma of the oesophago-gastric junction have a predominantly early, haematogenous pattern of recurrence. There is a need to better identify the group of patients with small metastases at the time of diagnosis who are destined to develop recurrent disease in order that they may be spared surgery and those with micro metastases in order that they can be offered multi-modality therapy including early post operative or neo-adjuvant chemotherapy.


British Journal of Surgery | 2008

Spontaneous rupture of the oesophagus

S. M. Griffin; Peter J. Lamb; Jonathan Shenfine; David Richardson; D. Karat; N. Hayes

The aim of this study was to evaluate the diagnosis, management and outcome of patients with spontaneous rupture of the oesophagus in a single centre.


British Journal of Surgery | 2012

Randomized clinical trial of omega-3 fatty acid-supplemented enteral nutrition versus standard enteral nutrition in patients undergoing oesophagogastric cancer surgery

J. Sultan; S. M. Griffin; F. Di Franco; John A. Kirby; B. K. Shenton; Chris Seal; P. Davis; Y. K. S. Viswanath; S. R. Preston; N. Hayes

Oesophagogastric cancer surgery is immunosuppressive. This may be modulated by omega‐3 fatty acids (O‐3FAs). The aim of this study was to assess the effect of perioperative O‐3FAs on clinical outcome and immune function after oesophagogastric cancer surgery.


The American Journal of Gastroenterology | 2001

Esophageal mucin: an adherent mucus gel barrier is absent in the normal esophagus but present in columnar-lined Barrett’s esophagus

Joanna Dixon; Vicki Strugala; S. M. Griffin; Mark Welfare; Peter W. Dettmar; Adrian Allen; Jeffrey P. Pearson

OBJECTIVES:The presence of a protective adherent mucus gel barrier against gastric reflux in the healthy esophagus is uncertain. The aim was to characterize the surface mucin composition and determine the extent of any adherent mucus gel layer on the normal esophagus, and compare this with that in Barretts esophagus.METHODS:Isolated surface mucins were characterized by density centrifugation, gel filtration chromatography, and chemical composition. Adherent surface mucus was visualized in situ on unfixed and cryostat sections of mucosa and biopsies using a method that preserves mucus layer thickness.RESULTS:There was a complete absence of adherent mucus gel layers on normal human, pig, and rat esophagi. This was in contrast to the thick adherent mucous layer (median thickness = 100–200 μm) seen on the corresponding gastric mucosa. Small quantities of glycoprotein with a composition characteristic of a secretory mucin were isolated from the pig esophagus surface. The mucin, density range between 1.44 and 1.48 g·ml−1, contained 80% carbohydrate and was rich in serine, threonine, and proline. The mucin fragmented into smaller glycoprotein units on proteolysis and partially on reduction. Cryostat sections from columnar-lined esophageal biopsies had a substantial adherent surface mucous layer (median thickness = 90 μm, interquartile range = 84–94 μm) staining for neutral mucins (gastric-type epithelium) and acidic mucins (intestinal metaplasia).CONCLUSIONS:A secretory mucin, with an analysis distinct from that of gastric or salivary mucin, is present in very small quantities on the esophageal mucosa and in amounts insufficient to form an adherent gel layer. It is unlikely that mucus has a role in protecting the normal esophagus against reflux. However, an adherent mucous layer was observed over columnar-lined esophagus, and this may protect against reflux.


British Journal of Surgery | 2004

Prospective study of routine contrast radiology after total gastrectomy

P. J. Lamb; S. M. Griffin; M. V. Chandrashekar; David Richardson; Dayalan Karat; N. Hayes

The practice of routine contrast radiology before recommencing oral nutrition after total gastrectomy is not evidence based. The aim of this prospective study was to evaluate the clinical role and timing of this investigation.

Collaboration


Dive into the S. M. Griffin's collaboration.

Top Co-Authors

Avatar

N. Hayes

Royal Victoria Infirmary

View shared research outputs
Top Co-Authors

Avatar

J. Wayman

Royal Victoria Infirmary

View shared research outputs
Top Co-Authors

Avatar

Dayalan Karat

Royal Victoria Infirmary

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

D. Karat

Royal Victoria Infirmary

View shared research outputs
Top Co-Authors

Avatar

S. A. Raimes

Royal Victoria Infirmary

View shared research outputs
Top Co-Authors

Avatar

N Hayes

Royal Victoria Infirmary

View shared research outputs
Top Co-Authors

Avatar

Arul Immanuel

Royal Victoria Infirmary

View shared research outputs
Top Co-Authors

Avatar

P. J. Lamb

Royal Victoria Infirmary

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge